characteristics.text: SAMN43323646
characteristics.characteristic: External Id
characteristics.text: Tavazoie Lab, Columbia University
characteristics.characteristic: INSDC center name
characteristics.text: 2024-08-24T00:50:14.990Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-08-24T00:50:14.990Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS22446452
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS22446452
characteristics.characteristic: SRA accession
characteristics.text: MG1655
characteristics.characteristic: cell type
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: wildtype and metG*
characteristics.characteristic: genotype
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: Escherichia coli
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_562
characteristics.characteristic: organism
characteristics.text: MG1655
characteristics.characteristic: source_name
characteristics.text: SB851d
characteristics.characteristic: title
characteristics.text: after overnight growth (all), diluted into fresh media + ampicillin (200 μg/mL) and incubated for 4 hours (metG_imm_abx_20230919) or diluted into fresh media + rifampicin (200 μg/ml) or tetracycline (135 μg/ml) and incubated for 1 hour (rif1hr_20230919, tet1hr_20230919)
characteristics.characteristic: treatment
characteristics.text: PETRI-seq; metG* in ampicillin, MG1655 in rifampicin, MG1655 in tetracycline
characteristics.characteristic: treatment